Strategies to reduce out-of-pocket medication costs for Canadians with peripheral arterial disease
Canadian Journal of Surgery · 2024
DOI: 10.1503/cjs.003722 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Surgery, 2024. Verfasst von Graham R McClure und 12 weiteren Autor:innen. Beteiligte Einrichtung: From the Division of Vascular Surgery, McMaster University, Hamilton, Ont. (McClure); the Department of Clinical Epidemiology and Biostatistics, McMa…. Hauptthemen laut MEDLINE: Drugs, Generic, Peripheral Arterial Disease, Health Expenditures, Drug Costs. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR.
Abstract (Originalsprache)
BACKGROUND: Given that peripheral arterial disease (PAD) disproportionately affects people of lower socioeconomic status, out-of-pocket expenses for preventive medications are a major barrier to their use. We carried out a cost comparison of drug therapies for PAD to identify prescribing strategies that minimize out-of-pocket expenses for these medications. METHODS: Between March and June 2019, we contacted outpatient pharmacies in Hamilton, Ontario, Canada, to assess pricing of pharmacologic therapies at dosages included in the 2016 American College of Cardiology/American Heart Association guideline for management of lower extremity PAD. We also gathered pricing information for supplementary charges, including delivery, pill splitting and blister packaging. We calculated prescription prices with and without dispensing fees for 30-day brand-name and generic prescriptions, and 90-day generic prescriptions. RESULTS: Twenty-four pharmacies, including hospital-based, independent and chain, were included in our sample. In the most extreme scenario, total 90-day medication costs could differ by up to $1377.26. Costs were affected by choice of agent within a drug class, generic versus brand-name drug, quantity dispensed, dispensing fee and delivery cost, if any. CONCLUSION: By opting for prescriptions for 90 days or as long as possible, selecting the lowest-cost generic drugs available in each drug class, and identifying dispensing locations with lower fees, prescribers can minimize out-of-pocket patient medication expenses. This may help improve adherence to guideline-recommended therapies for the secondary prevention of vascular events in patients with PAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Division of Vascular Surgery, McMaster University, Hamilton, Ont. (McClure); the Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ont. (McClure, McIntyre, Whitlock, Anand, B…
Förderung
- CIHR
Zitieren
APA
McClure, G. R., McIntyre, W. F., Belesiotis, P., Kaplovitch, E., Chan, N., Bhagirath, V., Chahill, G., Hayes, A., Sohi, G., Bordman, W., Whitlock, R. P., Anand, S. S., & Belley-Côté, E. P. (2024). Strategies to reduce out-of-pocket medication costs for Canadians with peripheral arterial disease. Canadian Journal of Surgery. https://doi.org/10.1503/cjs.003722
Vancouver
McClure GR, McIntyre WF, Belesiotis P, Kaplovitch E, Chan N, Bhagirath V, et al. Strategies to reduce out-of-pocket medication costs for Canadians with peripheral arterial disease. Canadian Journal of Surgery. 2024. doi:10.1503/cjs.003722
BibTeX
@article{McClure2024,
author = {McClure, Graham R and McIntyre, William F and Belesiotis, Peter and Kaplovitch, Eric and Chan, Noel and Bhagirath, Vinai and Chahill, Gurneet and Hayes, Abigail and Sohi, Gursharan and Bordman, Wendy and Whitlock, Richard P and Anand, Sonia S and Belley-Côté, Emilie P},
title = {Strategies to reduce out-of-pocket medication costs for Canadians with peripheral arterial disease},
journal = {Canadian Journal of Surgery},
year = {2024},
doi = {10.1503/cjs.003722}
}
EUVIMED